Buchang Pharmaceuticals Subsidiary Completes Industrial, Commercial Registration

MT Newswires Live
Feb 14, 2025

Shandong Buchang Pharmaceuticals (SHA:603858) said subsidiary Changrui Biotechnology completed its industrial and commercial registration.

The subsidiary has obtained the business license reissued by the Chengdu High-tech Industrial Development Zone Market Supervision and Administration Bureau, according to a Friday filing with the Shanghai bourse.

Shares of the pharmaceutical company rose 2% Friday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10